Replimune (REPL) Depreciation and Depletion (2020 - 2024)
Replimune's (REPL) quarterly Depreciation and Depletion came in at $700000.0 in Q2 2024, up 16.67% year-on-year from $600000.0 in Q3 2023, and little changed quarter-over-quarter from $700000.0 in Q4 2023.
Replimune (REPL) Depreciation and Depletion (2020 - 2024) Analysis & Trends
Replimune has disclosed Depreciation and Depletion across 5 years of filings, most recently posting $700000.0 for Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 600,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Sep 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 620,000.00 |
| Jun 30, 2022 | 620,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Dec 31, 2021 | 548,000.00 |
| Sep 30, 2021 | 532,000.00 |
| Sep 30, 2021 | 532,000.00 |
| Jun 30, 2021 | 518,000.00 |
| Jun 30, 2021 | 518,000.00 |